Phase 3 studies comparing brodalumab with ustekinumab in psoriasis

M. Lebwohl, B. Strober, A. Menter, K. Gordon, J. Weglowska, L. Puig, K. Papp, L. Spelman, D. Toth, F. Kerdel, A. W. Armstrong, G. Stingl, A. B. Kimball, H. Bachelez, J. J. Wu, J. Crowley, R. G. Langley, T. Blicharski, C. Paul, J. P. LacourS. Tyring, L. Kircik, S. Chimenti, K. C. Duffin, J. Bagel, J. Koo, G. Aras, J. Li, W. Song, C. E. Milmont, Y. Shi, N. Erondu, P. Klekotka, B. Kotzin, A. Nirula

Research output: Contribution to journalArticlepeer-review

690 Citations (Scopus)
Original languageEnglish
Pages (from-to)1318-1328
Number of pages11
JournalNew England Journal of Medicine
Volume373
Issue number14
DOIs
Publication statusPublished - Oct 1 2015

ASJC Scopus Subject Areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Phase 3 studies comparing brodalumab with ustekinumab in psoriasis'. Together they form a unique fingerprint.

Cite this